Euromedis Groupe SA(GB:0I0L)
€5.050.00 (0.00%)
GB:0I0L
Euromedis Groupe SA financials statements
€5.05
At close:0.00 (0.00%)
Euromedis Groupe SA (0I0L) Ratios
0 Followers
Euromedis Groupe SA Ratios
GB:0I0L's free cash flow for Q4 2025 was €0.00. For the 2025 fiscal year, GB:0I0L's free cash flow was increased by €0.00 and operating cash flow was €0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.47 | 3.53 | 2.58 | 5.43 | 4.71 |
| Quick Ratio | 1.78 | 2.41 | 1.87 | 4.12 | 3.85 |
| Cash Ratio | 1.08 | 1.42 | 1.24 | 2.81 | 2.33 |
| Solvency Ratio | 0.02 | -0.26 | 0.60 | -0.19 | 0.12 |
| Operating Cash Flow Ratio | 0.00 | 0.00 | 0.00 | -0.11 | 1.41 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -349.33 | 35.58 |
| Net Current Asset Value | € 15.20M | € 15.34M | € 15.63M | € 26.89M | € 32.93M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.21 | 0.22 | 0.21 | 0.21 |
| Debt-to-Equity Ratio | 0.37 | 0.49 | 0.44 | 0.37 | 0.38 |
| Debt-to-Capital Ratio | 0.27 | 0.33 | 0.31 | 0.27 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.23 | 0.33 | 0.18 | 0.27 | 0.26 |
| Financial Leverage Ratio | 2.40 | 2.35 | 2.05 | 1.73 | 1.77 |
| Debt Service Coverage Ratio | 0.13 | -2.12 | -0.89 | -11.43 | 4.48 |
| Interest Coverage Ratio | 0.89 | 0.79 | -15.92 | -14.58 | 9.44 |
| Debt to Market Cap | 0.54 | 0.80 | 0.66 | 0.91 | 0.48 |
| Interest Debt Per Share | 2.25 | 3.00 | 3.64 | 4.52 | 5.32 |
| Net Debt to EBITDA | -12.07 | 1.33 | 1.99 | 3.10 | -3.72 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.15% | 5.32% | 9.54% | 34.60% | 29.93% |
| EBIT Margin | 0.77% | -15.47% | -14.85% | -10.39% | 2.58% |
| EBITDA Margin | 2.14% | -14.86% | -11.85% | -8.32% | 3.92% |
| Operating Profit Margin | 0.77% | 1.10% | -15.31% | -10.44% | 3.31% |
| Pretax Profit Margin | 1.35% | 1.04% | 35.75% | -11.07% | 2.25% |
| Net Profit Margin | -0.32% | -16.87% | 35.03% | -10.99% | 2.02% |
| Continuous Operations Profit Margin | -0.32% | 1.05% | 35.03% | -10.96% | 2.06% |
| Net Income Per EBT | -23.93% | -1621.43% | 97.99% | 99.32% | 89.74% |
| EBT Per EBIT | 175.99% | 94.96% | -233.52% | 105.97% | 67.96% |
| Return on Assets (ROA) | -0.33% | -15.75% | 28.34% | -9.95% | 3.10% |
| Return on Equity (ROE) | -0.80% | -37.06% | 58.03% | -17.16% | 5.50% |
| Return on Capital Employed (ROCE) | 1.30% | 1.41% | -18.47% | -11.24% | 6.26% |
| Return on Invested Capital (ROIC) | -0.30% | 1.32% | -15.62% | -11.17% | 5.69% |
| Return on Tangible Assets | -0.34% | -15.82% | 28.36% | -10.40% | 3.23% |
| Earnings Yield | -1.17% | -48.73% | 86.50% | -42.35% | 7.19% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.79 | 4.19 | 4.40 | 6.13 | 7.77 |
| Payables Turnover | 2.87 | 3.59 | 4.34 | 4.85 | 7.47 |
| Inventory Turnover | 2.64 | 2.87 | 3.13 | 2.81 | 6.67 |
| Fixed Asset Turnover | 58.89 | 44.56 | 59.71 | 12.53 | 25.44 |
| Asset Turnover | 1.03 | 0.93 | 0.81 | 0.91 | 1.54 |
| Working Capital Turnover Ratio | 1.64 | 1.42 | 1.13 | 1.16 | 2.24 |
| Cash Conversion Cycle | 107.33 | 112.63 | 115.33 | 113.99 | 52.80 |
| Days of Sales Outstanding | 96.38 | 87.10 | 83.00 | 59.59 | 46.95 |
| Days of Inventory Outstanding | 138.05 | 127.13 | 116.51 | 129.69 | 54.74 |
| Days of Payables Outstanding | 127.10 | 101.60 | 84.18 | 75.28 | 48.89 |
| Operating Cycle | 234.43 | 214.23 | 199.51 | 189.28 | 101.69 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | 0.00 | -0.36 | 6.44 |
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | -0.71 | 5.82 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -1.02 | 10.47 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -1.02 | 10.47 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | -0.08 | 1.24 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -0.02 | 0.17 |
| Free Cash Flow Yield | 0.00% | 0.00% | 0.00% | -14.79% | 55.45% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -85.03 | -2.05 | 1.16 | -2.36 | 13.92 |
| Price-to-Sales (P/S) Ratio | 0.28 | 0.35 | 0.40 | 0.26 | 0.28 |
| Price-to-Book (P/B) Ratio | 0.68 | 0.76 | 0.67 | 0.41 | 0.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 0.00 | 0.00 | -6.76 | 1.80 |
| Price-to-Operating Cash Flow Ratio | 0.00 | 0.00 | 0.00 | -13.42 | 1.63 |
| Price-to-Earnings Growth (PEG) Ratio | 0.87 | 0.01 | -0.00 | 0.01 | -0.15 |
| Enterprise Value Multiple | 0.80 | -1.00 | -1.43 | -0.02 | 3.43 |
| Enterprise Value | 701.02K | 5.39M | 6.33M | 99.45K | 15.06M |
| EV to EBITDA | 0.80 | -1.00 | -1.43 | -0.02 | 3.43 |
| EV to Sales | 0.02 | 0.15 | 0.17 | 0.00 | 0.13 |
| EV to Free Cash Flow | 0.00 | 0.00 | 0.00 | -0.05 | 0.87 |
| EV to Operating Cash Flow | 0.00 | 0.00 | 0.00 | -0.09 | 0.78 |
| Tangible Book Value Per Share | 5.62 | 5.72 | 7.92 | 11.03 | 12.87 |
| Shareholders’ Equity Per Share | 5.72 | 5.79 | 7.93 | 11.87 | 13.71 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 1.24 | -0.01 | 0.02 | 0.01 | 0.08 |
| Revenue Per Share | 14.20 | 12.71 | 13.14 | 18.53 | 37.42 |
| Net Income Per Share | -0.05 | -2.14 | 4.60 | -2.04 | 0.75 |
| Tax Burden | -0.24 | -16.21 | 0.98 | 0.99 | 0.90 |
| Interest Burden | 1.76 | -0.07 | -2.41 | 1.06 | 0.87 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.02 | 0.00 | 0.00 | 0.00 | 0.16 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.00 | 0.00 | 0.00 | 0.18 | 8.35 |
Currency in EUR
